Impact Biomedical reported revenue of $0.00M and net income of -$0.70M for the quarter ended Jun 2026, down 57.1% year over year. This income statement covers 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||
| Revenue | 0.05M | 0.01M | 0.02M | 0.01M | 0.00M | ||||||||||||
| Cost of RevenueCost of Rev | 0.00M | 0.00M | 0.00M | ||||||||||||||
| Gross Profit | 0.01M | 0.02M | 0.00M | ||||||||||||||
| Operating items | |||||||||||||||||
| Depreciation & Amortization - TotalDep. & Amort. (Tot) | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | |||||
| Research & DevelopmentR&D | 0.21M | 0.33M | 0.52M | 0.18M | 0.27M | 0.36M | 0.63M | 0.18M | 0.12M | 0.46M | 0.15M | 0.10M | 0.07M | 0.05M | 0.05M | 0.08M | |
| Selling, General & AdministrativeSG&A | 0.06M | 0.09M | 0.04M | 0.04M | 0.04M | 0.10M | 0.13M | 0.15M | 0.14M | 0.13M | 0.29M | 0.25M | 0.25M | 0.26M | -0.44M | 1.62M | 0.17M |
| Restructuring CostsRestructuring | 0.03M | 0.01M | 0.03M | 0.01M | 0.02M | 0.12M | |||||||||||
| Other Operating ExpensesOther Opex | 0.51M | 0.46M | 0.44M | 0.58M | 0.69M | 0.60M | 0.25M | 0.44M | 0.36M | 0.53M | 25.79M | 0.66M | 0.84M | 0.65M | 0.63M | 0.46M | |
| Operating ExpensesOpex | 0.80M | 0.89M | 1.03M | 0.80M | 1.01M | 1.08M | 1.14M | 0.77M | 0.63M | 1.13M | 26.23M | 1.01M | 1.16M | 0.97M | -0.44M | 2.30M | 0.70M |
| Operating IncomeOp. Inc | -0.75M | -0.89M | -1.03M | -0.80M | -1.01M | -1.08M | -1.14M | -0.77M | -0.63M | -1.13M | -26.23M | -1.01M | -1.15M | -0.95M | -2.29M | -0.70M | |
| EBIT | -0.75M | -0.89M | -1.03M | -0.80M | -1.01M | -1.08M | -1.14M | -0.77M | -0.63M | -1.13M | -26.23M | -1.01M | -1.15M | -0.95M | -2.29M | -0.70M | |
| Non-operating items | |||||||||||||||||
| Non Operating Interest Expenses | 0.14M | 0.09M | 0.10M | 0.10M | 0.12M | 0.10M | 0.12M | 0.23M | 0.26M | 0.30M | 0.27M | 0.27M | 0.26M | 0.26M | 0.07M | 0.07M | |
| Interest & Investment IncomeInt & Inv Inc | 0.09M | 0.00M | -0.08M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.00M | |
| Other Non Operating IncomeOther Non Op Inc. | 0.05M | 5.67M | |||||||||||||||
| Net income details | |||||||||||||||||
| EBT | -0.80M | -0.98M | -5.25M | -0.85M | -1.12M | -1.18M | -1.26M | -1.00M | -0.88M | 4.24M | -27.10M | -1.28M | -14.35M | -1.48M | -2.28M | -0.70M | |
| Tax ProvisionsTaxes | 1.26M | -1.88M | |||||||||||||||
| Profit After TaxPAT | -0.80M | -2.24M | -3.37M | -0.85M | -1.12M | -1.18M | -1.26M | -1.00M | -0.89M | 4.25M | -27.17M | -1.28M | -14.35M | -1.48M | -2.29M | -0.70M | |
| Income from Non-Controlling InterestsInc. Minority | -0.07M | -0.07M | 0.20M | -0.19M | -0.02M | -0.01M | -0.03M | -0.04M | 0.01M | -0.01M | -0.03M | -0.01M | -0.01M | -0.01M | 0.00M | -0.00M | |
| Income from Continuing OperationsIncome (Continuing) | -0.80M | -2.24M | -3.37M | -0.85M | -1.12M | -1.18M | -1.26M | -1.00M | -0.88M | 4.24M | -27.10M | -1.28M | -14.35M | -1.48M | -2.28M | -0.70M | |
| Consolidated Net IncomeConsol Net Inc. | -0.80M | -2.24M | -3.37M | -0.85M | -1.12M | -1.18M | -1.26M | -1.00M | -0.88M | 4.24M | -27.10M | -1.28M | -14.35M | -1.48M | -2.28M | -0.70M | |
| Income towards Parent CompanyParent Net Inc | -0.80M | -2.24M | -3.37M | -0.85M | -1.12M | -1.18M | -1.26M | -1.00M | -0.88M | 4.24M | -27.10M | -1.28M | -14.35M | -1.48M | -2.28M | -0.70M | |
| Net Income towards Common StockholdersNet Income | -0.73M | -2.17M | -3.36M | -0.66M | -1.10M | -1.16M | -1.24M | -0.96M | -0.89M | 4.25M | -27.10M | -1.28M | -14.35M | -1.48M | -2.28M | -0.70M | |
| Additional items | |||||||||||||||||
| EPS (Basic) | 0.00 | -0.03 | -0.05 | -0.01 | -0.02 | -0.02 | -0.02 | -0.10 | -0.09 | 0.37 | -2.52 | -0.11 | -1.18 | -0.12 | -0.02 | -0.01 | |
| Shares Outstanding | 3,877.28M | 70.50M | 70.50M | 70.50M | 70.50M | 70.50M | 60.25M | 10.00M | 10.00M | 11.50M | 10.76M | 12.06M | 12.19M | 12.19M | 31.55M | 107.79M | 107.82M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 3,877.28M | 70.50M | 70.50M | 70.50M | 70.50M | 70.50M | 60.25M | 10.00M | 10.00M | 11.50M | 11.50M | 12.09M | 12.19M | 12.19M | 31.55M | 107.82M | 107.82M |
| EBITDA | -0.75M | -0.89M | -1.03M | -0.80M | -1.01M | -1.08M | -1.14M | -0.77M | -0.62M | -1.12M | -26.23M | -1.01M | -1.15M | -0.95M | -2.29M | -0.70M | |
| Interest ExpensesInt Expense | 0.14M | 0.09M | 0.10M | 0.10M | 0.12M | 0.10M | 0.12M | 0.23M | 0.26M | 0.30M | 0.27M | 0.27M | 0.26M | 0.26M | 0.07M | 0.07M | |
| Tax Rate | -128.63% | 35.82% |